Credit Suisse’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-254,090
| Closed | -$9.57M | – | 3779 |
|
2021
Q1 | $9.57M | Buy |
254,090
+233,124
| +1,112% | +$8.78M | ﹤0.01% | 1193 |
|
2020
Q4 | $357K | Buy |
+20,966
| New | +$357K | ﹤0.01% | 3088 |
|
2019
Q4 | – | Sell |
-24,513
| Closed | -$95K | – | 3635 |
|
2019
Q3 | $95K | Sell |
24,513
-7,849
| -24% | -$30.4K | ﹤0.01% | 3300 |
|
2019
Q2 | $195K | Buy |
32,362
+6,406
| +25% | +$38.6K | ﹤0.01% | 3207 |
|
2019
Q1 | $349K | Sell |
25,956
-1,831
| -7% | -$24.6K | ﹤0.01% | 2957 |
|
2018
Q4 | $258K | Buy |
27,787
+4,666
| +20% | +$43.3K | ﹤0.01% | 3051 |
|
2018
Q3 | $321K | Sell |
23,121
-18,508
| -44% | -$257K | ﹤0.01% | 3020 |
|
2018
Q2 | $658K | Sell |
41,629
-4,810
| -10% | -$76K | ﹤0.01% | 2840 |
|
2018
Q1 | $798K | Buy |
46,439
+10,526
| +29% | +$181K | ﹤0.01% | 2711 |
|
2017
Q4 | $786K | Sell |
35,913
-51,214
| -59% | -$1.12M | ﹤0.01% | 2690 |
|
2017
Q3 | $3.57M | Sell |
87,127
-2,044
| -2% | -$83.7K | ﹤0.01% | 1688 |
|
2017
Q2 | $2.69M | Sell |
89,171
-18,622
| -17% | -$561K | ﹤0.01% | 1728 |
|
2017
Q1 | $3.9M | Buy |
107,793
+31,740
| +42% | +$1.15M | ﹤0.01% | 1568 |
|
2016
Q4 | $3.81M | Sell |
76,053
-643
| -0.8% | -$32.2K | ﹤0.01% | 1611 |
|
2016
Q3 | $4.03M | Buy |
76,696
+12,325
| +19% | +$647K | ﹤0.01% | 1588 |
|
2016
Q2 | $2.66M | Buy |
64,371
+4,352
| +7% | +$180K | ﹤0.01% | 1881 |
|
2016
Q1 | $2.44M | Buy |
60,019
+51,067
| +570% | +$2.08M | ﹤0.01% | 1832 |
|
2015
Q4 | $371K | Sell |
8,952
-4,572
| -34% | -$189K | ﹤0.01% | 3347 |
|
2015
Q3 | $208K | Sell |
13,524
-45,073
| -77% | -$693K | ﹤0.01% | 3694 |
|
2015
Q2 | $1.46M | Buy |
58,597
+17,807
| +44% | +$442K | ﹤0.01% | 2596 |
|
2015
Q1 | $932K | Buy |
40,790
+21,753
| +114% | +$497K | ﹤0.01% | 2778 |
|
2014
Q4 | $514K | Buy |
+19,037
| New | +$514K | ﹤0.01% | 3335 |
|